Published in J Biol Chem on September 25, 2012
SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat Neurosci (2013) 1.30
Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis. Haematologica (2014) 0.84
The nucleosome remodeling and deacetylase complex in development and disease. Transl Res (2014) 0.83
Global analysis of induced transcription factors and cofactors identifies Tfdp2 as an essential coregulator during terminal erythropoiesis. Exp Hematol (2014) 0.80
Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators. FASEB J (2014) 0.78
Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells. Int J Biochem Cell Biol (2014) 0.77
Acetylation of HDAC1 and degradation of SIRT1 form a positive feedback loop to regulate p53 acetylation during heat-shock stress. Cell Death Dis (2015) 0.76
Pregnancy-secreted Acid phosphatase, uteroferrin, enhances fetal erythropoiesis. Endocrinology (2014) 0.76
Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins. J Biol Chem (2016) 0.76
Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly. FASEB J (2017) 0.75
Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A (1971) 11.41
Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell (2009) 8.69
The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell (1998) 7.37
The erythroid-specific transcription factor Eryf1: a new finger protein. Cell (1989) 6.14
MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet (1999) 5.61
Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene (2002) 4.80
A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr Biol (1998) 4.63
Immunoaffinity purification of mammalian protein complexes. Methods Enzymol (2003) 4.54
Histone deacetylases and cancer. Oncogene (2007) 4.30
Global regulation of erythroid gene expression by transcription factor GATA-1. Blood (2004) 4.22
Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol (1997) 4.12
Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell (2009) 3.96
Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev (1991) 3.61
dMi-2, a hunchback-interacting protein that functions in polycomb repression. Science (1998) 3.48
GATA-1 binding sites mapped in the beta-globin locus by using mammalian chIp-chip analysis. Proc Natl Acad Sci U S A (2002) 3.41
GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A (2003) 3.32
CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc Natl Acad Sci U S A (1998) 3.22
Histone deacetylases, transcriptional control, and cancer. J Cell Physiol (2000) 3.18
NuRD and SIN3 histone deacetylase complexes in development. Trends Genet (2000) 3.14
GATA transcription factors: key regulators of hematopoiesis. Exp Hematol (1995) 3.09
Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell (2009) 3.05
Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem (2000) 2.89
Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. Mol Cell (1999) 2.66
GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood (1999) 2.62
GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J (2005) 2.56
The chromatin remodeler Mi-2beta is required for CD4 expression and T cell development. Immunity (2004) 2.54
FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO J (2005) 2.53
GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol (2003) 2.52
The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev (2001) 2.48
GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol (2004) 2.10
Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1. Mol Cell Biol (2003) 2.09
Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration. Genome Res (2011) 2.07
Context-dependent regulation of GATA-1 by friend of GATA-1. Proc Natl Acad Sci U S A (2003) 2.01
Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc Natl Acad Sci U S A (2004) 1.99
Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol Cell Biol (2006) 1.94
Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter. Proc Natl Acad Sci U S A (2001) 1.94
Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell (2002) 1.81
The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol Cell Biol (2003) 1.77
Role of class I and class II histone deacetylases in carcinoma cells using siRNA. Biochem Biophys Res Commun (2003) 1.73
Valproic acid for the treatment of myeloid malignancies. Cancer (2007) 1.69
HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell (2006) 1.67
Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation. Int J Dev Biol (2009) 1.66
NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. EMBO J (2009) 1.66
BRG1 requirement for long-range interaction of a locus control region with a downstream promoter. Proc Natl Acad Sci U S A (2009) 1.65
LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci U S A (2009) 1.58
Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene (2007) 1.52
Genetic dissection of histone deacetylase requirement in tumor cells. Proc Natl Acad Sci U S A (2009) 1.46
Differences in the chromatin structure and cis-element organization of the human and mouse GATA1 loci: implications for cis-element identification. Blood (2004) 1.43
Vorinostat in solid and hematologic malignancies. J Hematol Oncol (2009) 1.42
Dynamic GATA factor interplay at a multicomponent regulatory region of the GATA-2 locus. J Biol Chem (2004) 1.37
Dissecting molecular steps in chromatin domain activation during hematopoietic differentiation. Mol Cell Biol (2007) 1.34
Individual histone deacetylases in Drosophila modulate transcription of distinct genes. Genomics (2005) 1.26
P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J (2000) 1.25
Silencing of Agamma-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site. Mol Cell Biol (2008) 1.25
mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol (2000) 1.24
MBD family proteins: reading the epigenetic code. J Cell Sci (2006) 1.22
Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res (2006) 1.22
Identification and functional characterization of the p66/p68 components of the MeCP1 complex. Mol Cell Biol (2002) 1.18
Heterogeneous nuclear ribonucleoprotein C1/C2, MeCP1, and SWI/SNF form a chromatin remodeling complex at the beta-globin locus control region. Proc Natl Acad Sci U S A (2005) 1.15
Dissecting the biological functions of Drosophila histone deacetylases by RNA interference and transcriptional profiling. J Biol Chem (2006) 1.15
Chfr is linked to tumour metastasis through the downregulation of HDAC1. Nat Cell Biol (2009) 1.12
Controlling hematopoiesis through sumoylation-dependent regulation of a GATA factor. Mol Cell (2009) 1.09
Trans-regulation of histone deacetylase activities through acetylation. J Biol Chem (2009) 1.06
Control of beta globin genes. J Cell Biochem (2007) 1.04
MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells. Blood (2006) 1.01
Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system. Anticancer Res (1985) 0.93
Role of GATA-1 in normal and neoplastic hemopoiesis. Ann N Y Acad Sci (2005) 0.93
Dynamic interaction of HDAC1 with a glucocorticoid receptor-regulated gene is modulated by the activity state of the promoter. J Biol Chem (2010) 0.90
Translational isoforms of FOG1 regulate GATA1-interacting complexes. J Biol Chem (2009) 0.85
Methods for analysis of nucleosome sliding by Drosophila NURF. Methods Enzymol (2004) 0.83
Regulation of GATA1 gene expression. J Biochem (2007) 0.83
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol (2011) 18.34
Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med (2005) 8.49
Identification of an acquired JAK2 mutation in polycythemia vera. J Biol Chem (2005) 5.58
Falling off the academic bandwagon. Women are more likely to quit at the postdoc to principal investigator transition. EMBO Rep (2007) 4.58
Recruitment of histone modifications by USF proteins at a vertebrate barrier element. Mol Cell (2004) 3.08
A 160-kilobit molecular electronic memory patterned at 10(11) bits per square centimetre. Nature (2007) 2.48
Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice. Blood (2008) 2.37
Meta-analysis suggests that smoking is associated with an increased risk of early natural menopause. Menopause (2012) 2.36
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med (2007) 2.17
Transfer of metals from soil to vegetables in an area near a smelter in Nanning, China. Environ Int (2004) 2.16
In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials (2003) 2.08
Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules (2002) 2.06
Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res (2011) 2.00
Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol Cell Biol (2003) 1.92
Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Mol Cell Biol (2002) 1.80
Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol (2007) 1.79
How independent are the appearances of n-mers in different genomes? Bioinformatics (2004) 1.70
USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. Mol Cell Biol (2007) 1.68
HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription. Mol Cell (2006) 1.67
Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol Cell Biol (2002) 1.61
Dinitrogen cleavage and hydrogenation by a trinuclear titanium polyhydride complex. Science (2013) 1.61
The human beta-globin locus control region. Eur J Biochem (2002) 1.60
LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci U S A (2009) 1.58
Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth. J Biol Chem (2006) 1.55
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy. Oncotarget (2014) 1.51
JAK2(V617F): Prevalence in a large Chinese hospital population. Blood (2006) 1.50
InGaN/GaN multilayer quantum dots yellow-green light-emitting diode with optimized GaN barriers. Nanoscale Res Lett (2012) 1.46
SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood (2004) 1.44
Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia. Acta Haematol (2012) 1.43
Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosis. PLoS Genet (2010) 1.41
T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis. Am J Pathol (2004) 1.39
Concomitant irrigated monopolar radiofrequency ablation of atrial fibrillation in adults with congenital heart disease. Interact Cardiovasc Thorac Surg (2007) 1.39
Effects of active and passive smoking on the development of cardiovascular disease as assessed by a carotid intima-media thickness examination in patients with type 2 diabetes mellitus. Clin Exp Pharmacol Physiol (2015) 1.38
Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing. Biomaterials (2002) 1.38
Exposure to metal mixtures and human health impacts in a contaminated area in Nanning, China. Environ Int (2005) 1.38
Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A (2004) 1.37
GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration. Dev Cell (2011) 1.31
A human ECG identification system based on ensemble empirical mode decomposition. Sensors (Basel) (2013) 1.30
SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat Neurosci (2013) 1.30
Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities. J Biol Inorg Chem (2009) 1.28
Bladder Cancer Immunotherapy: BCG and Beyond. Adv Urol (2012) 1.27
Exploration of α-aminophosphonate N-derivatives as novel, potent and selective inhibitors of protein tyrosine phosphatases. Eur J Med Chem (2012) 1.26
Characterization of the human beta-globin downstream promoter region. Nucleic Acids Res (2003) 1.24
Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun (2012) 1.24
Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochem Biophys Res Commun (2012) 1.23
Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity. Cancer Res (2004) 1.23
Bridging dimensions: demultiplexing ultrahigh-density nanowire circuits. Science (2005) 1.23
Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435. J Lipid Res (2003) 1.21
Recruitment of transcription complexes to the beta-globin gene locus in vivo and in vitro. J Biol Chem (2004) 1.21
Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure. J Biol Chem (2002) 1.20
USF and NF-E2 cooperate to regulate the recruitment and activity of RNA polymerase II in the beta-globin gene locus. J Biol Chem (2010) 1.20
Chromatin dynamics and the evolution of alternate promoter states. Chromosome Res (2006) 1.19
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer. J Thorac Oncol (2011) 1.19
microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol (2011) 1.18
Antagonistic regulation of beta-globin gene expression by helix-loop-helix proteins USF and TFII-I. Mol Cell Biol (2006) 1.18
Mononuclear copper(II) complexes with 3,5-substituted-4-salicylidene-amino-3,5-dimethyl-1,2,4-triazole: synthesis, structure and potent inhibition of protein tyrosine phosphatases. Dalton Trans (2011) 1.17
Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood (2011) 1.17
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. Clin Immunol (2005) 1.16
H4R3 methylation facilitates beta-globin transcription by regulating histone acetyltransferase binding and H3 acetylation. Blood (2010) 1.14
Linear structural evolution induced tunable photoluminescence in clinopyroxene solid-solution phosphors. Sci Rep (2013) 1.14
Occurrence of sulfonamide and tetracycline-resistant bacteria and resistance genes in aquaculture environment. Water Res (2012) 1.13
The flexible fairness: equality, earned entitlement, and self-interest. PLoS One (2013) 1.11
Berberine suppresses androgen receptor signaling in prostate cancer. Mol Cancer Ther (2011) 1.11
Occurrence and source analysis of typical veterinary antibiotics in manure, soil, vegetables and groundwater from organic vegetable bases, northern China. Environ Pollut (2010) 1.09
Hematopoietic stem cell injury induced by ionizing radiation. Antioxid Redox Signal (2014) 1.09
High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma. Cancer Sci (2008) 1.09
Tuning chemical enhancement of SERS by controlling the chemical reduction of graphene oxide nanosheets. ACS Nano (2011) 1.08
Combining chromatin immunoprecipitation and DNA footprinting: a novel method to analyze protein-DNA interactions in vivo. Nucleic Acids Res (2002) 1.08
The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling. J Biol Chem (2007) 1.07
Trans-regulation of histone deacetylase activities through acetylation. J Biol Chem (2009) 1.06
Hepatic erythropoietin gene regulation by GATA-4. J Biol Chem (2003) 1.06
The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro. J Control Release (2010) 1.06
[Diagnosis and treatment of aortic origin of the right pulmonary artery: analysis of 14 cases]. Zhonghua Yi Xue Za Zhi (2009) 1.05
Assembly and structural analysis of a covalently closed nano-scale DNA cage. Nucleic Acids Res (2007) 1.04
Overlapping-based optical freeform surface construction for extended lighting source. Opt Express (2013) 1.03
USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription. PLoS Genet (2013) 1.03
In vivo cleavage of alpha2,6-sialyltransferase by Alzheimer beta-secretase. J Biol Chem (2004) 1.02
Aquaporin-4 deficiency impairs synaptic plasticity and associative fear memory in the lateral amygdala: involvement of downregulation of glutamate transporter-1 expression. Neuropsychopharmacology (2012) 1.02
Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax protein. J Biol Chem (2012) 1.01
O-glycosylation of EGF repeats: identification and initial characterization of a UDP-glucose: protein O-glucosyltransferase. Glycobiology (2002) 1.01
The unidirectional valve patch provides no benefits to early and long-term survival in patients with ventricular septal defect and severe pulmonary artery hypertension. J Thorac Cardiovasc Surg (2009) 1.01
Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer. PLoS One (2012) 1.00
The role of entecavir in preventing hepatitis B recurrence after liver transplantation. J Dig Dis (2009) 1.00
Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation. J Biol Chem (2012) 1.00
Subnuclear trafficking and gene targeting by steroid receptors. Ann N Y Acad Sci (2004) 1.00